New products from Rx to OTC
FDA Approves Generic OTC Naloxone Nasal Spray
Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Issues CRL for Epidermolysis Bullosa Gene Therapy
Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
This approval is the second biosimilar approval for manufacturer Alvotech.
FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
